Lu et al. designed a novel NK-tailored chimeric costimulatory switching receptor containing PD-1 to convert inhibitory PD-1/PD-L1 signals into activating signals, thereby effectively enhancing the anti-tumor activity against lung cancer cells by triggering pyroptosis 10. The gene discussed is CD274; the disease is neoplasm.